Major depression is an illness that can be treated. It stands as
one of the most common psychiatric disorders, and affects about one in eight people.
The World Health Organization ranks depression as one of the top causes of suffering
and disability world wide, yet effective treatment is available.
Our research program is focused on improving treatments for depression.
Many of our projects examine how depression affects brain function, how brain activity changes when a person is
being treated, and how this information might be used to provide more effective care for people
with depression. Additionally, we are involved with developing and evaluating new treatments for depression.
Our clinical research projects are currently open for enrollment.
Please call us at 310-825-3351 to talk with someone
about participating, or for more information, please look at the PDF files of our flyers for:
- Project PRISE-MD, using FDA-approved antidepressant
medications and a new brain biomarker in adults (age 21-75)
- Project BOLD, using an FDA-approved antidepressant
medication and our brain activity biomarker in older adults (age 65 and up)
- our Co-Treatment Project in which we are evaluating
the use of an FDA-approved antidepressant medication plus a sleeping medication for depressed
adults with insomnia (age 18-64)
- our TMS Project using EEG biomarkers
and treatment with transcranial magnetic stimulation (TMS) (see box below) for adults (age 18-64)
